ATI RN
Pharmacology Assessment 2 ATI Capstone Questions
Question 1 of 5
The ophthalmologist asks the nurse to prepare to assist in the administration of tetracaine, fluorescein stain, and atropine for a diagnostic eye examination. Before assisting in the procedure, it is most important for the nurse to inform the ophthalmologist if the patient has a history of which condition?
Correct Answer: B
Rationale: Atropine is a mydriatic agent that dilates the pupil and can precipitate angle-closure glaucoma in patients with a narrow anterior chamber angle. Therefore, it is critical to inform the ophthalmologist if the patient has a history of angle-closure glaucoma. Cataracts (A), open-angle glaucoma (C), and macular degeneration (D) are not contraindications for the use of atropine.
Question 2 of 5
Which of the following adverse effects is specific to the biguanide diabetic drug metformin (Glucophage) therapy?
Correct Answer: B
Rationale: Metformin (Glucophage) is a biguanide medication used to manage type 2 diabetes. While it is generally well-tolerated, one of its rare but serious adverse effects is lactic acidosis, a condition characterized by the buildup of lactic acid in the bloodstream. This can occur in patients with renal impairment or other risk factors. Hypoglycemia is uncommon with metformin alone, and GI distress, though common, is not life-threatening. Somnolence is not typically associated with metformin. Therefore, lactic acidosis is the most specific and serious adverse effect.
Question 3 of 5
A 60-year-old epileptic woman who has been on the same dose of phenytoin for 20 years develops cerebellar ataxia with nystagmus. Her other medication consists of folic acid, hormone replacement therapy (HRT) and furosemide prescribed by the GP for ankle swelling and mild hypertension. She is referred to A&E. Routine investigations reveal an elevated plasma creatinine, normal plasma potassium and calcium, hypoalbuminaemia and proteinuria. The phenytoin concentration is 15 mg/L (therapeutic reference range 10-20 mg/L). A diagnosis of nephrotic syndrome is made and the cerebellar signs are attributed to phenytoin toxicity. Which of the following is likely to be correct?
Correct Answer: D
Rationale: Phenytoin toxicity (ataxia, nystagmus) occurs despite a ‘normal' total plasma level (15 mg/L) due to nephrotic syndrome's hypoalbuminemia. Normally, phenytoin is 90% protein-bound, with 10% free (active). Low albumin increases the free fraction (e.g., to 20%), raising CNS exposure despite a therapeutic total level. Creatinine doesn't typically interfere with phenytoin assays; they're reliable unless specific lab issues exist. Furosemide doesn't alter the blood-brain barrier for phenytoin; no evidence supports this. Oestrogen in HRT doesn't directly enhance phenytoin's CNS toxicity; it may affect metabolism, but not here. Cerebrovascular events don't fit the drug-related context. The increased free fraction explains toxicity, necessitating free level monitoring in hypoalbuminemia.
Question 4 of 5
Aspirin:
Correct Answer: B
Rationale: Aspirin, or acetylsalicylic acid, is metabolized to salicylic acid and acetic acid, not acetone, making the hydrolysis statement false. At low doses, it follows first-order kinetics, where elimination rate is proportional to concentration, a true statement reflecting its predictable clearance under therapeutic levels. It's primarily conjugated in the liver (e.g., to salicyluric acid), but excreted mainly via urine, not bile, so that's false. Aspirin irreversibly inhibits cyclooxygenase (COX) by acetylating it, unlike reversible NSAIDs, making that option false. The correct answer highlights aspirin's pharmacokinetic behavior at low doses, critical for its use in analgesia or cardioprotection, where steady-state effects depend on consistent elimination, contrasting with zero-order kinetics at overdose levels.
Question 5 of 5
The nurse is assessing a client and notes that he is receiving finasteride (Proscar). The client denies having any history of a significant prostate disorder. What is the best assessment question for the nurse to ask at this time?
Correct Answer: A
Rationale: Finasteride, a 5-alpha reductase inhibitor, is prescribed as Proscar for benign prostatic hyperplasia (BPH) but also as Propecia for male pattern baldness, reducing dihydrotestosterone levels to slow hair loss. Without a prostate disorder, baldness becomes a plausible alternative indication. Erectile dysfunction isn't treated by finasteride-it may even cause it as a side effect-making that question irrelevant. Stomach ulcers and high blood pressure have no connection to finasteride's mechanism, which targets androgen pathways, not gastrointestinal or cardiovascular systems. Asking about baldness aligns with finasteride's dual use, probing a condition tied to its action on hair follicles, offering a logical explanation for its prescription in the absence of BPH, and guiding the nurse's understanding of the client's treatment rationale.